Daniela Allende
Articles
-
1 month ago |
cell.com | Priya Prakash |Palak Manchanda |Kanchan Bisht |Kaushik P. Sharma |Victória M. Wendt |Ahad Hossain | +24 more
Keywordsmicroglialipidslipidomicslipid dropletsAlzheimer’s diseasemetabolismneurodegenerationamyloidphagocytosisDGAT2Get full text accessLog in, subscribe or purchase for full access. References1. Serrano-Pozo, A. ∙ Frosch, M.P. ∙ Masliah, E. ... Neuropathological alterations in Alzheimer diseaseCold Spring Harb. Perspect. Med. 2011; 1, a0061892. Zhao, Z. ∙ Liu, Y. ∙ Ruan, S. ... Current Anti-Amyloid-β Therapy for Alzheimer’s Disease Treatment: From Clinical Research to NanomedicineInt. J. Nanomedicine.
-
Dec 15, 2023 |
cancernetwork.com | Suneel Kamath |Joanna Roopkumar |Ying Ni |Minqian Shen |Pablo G. Bejarano |Daniela Allende | +9 more
December 15, 2023OncologyONCOLOGY Vol 37, Issue 12Pages: 488-495Suneel K. Kamath, MD, et al investigated exceptional responders and the correlation of nonsynonymous mutations for patients with advanced pancreatic cancer. ABSTRACTIntroduction: Exceptional response to therapy is rare in patients with advanced pancreatic cancer. This study explored potential genomic differences between typical and exceptional responses that could confer more favorable biology.
-
Dec 15, 2023 |
December 15, 2023OncologyONCOLOGY Vol 37, Issue 12Pages: 488-495Suneel K. Kamath, MD, et al investigated exceptional responders and the correlation of nonsynonymous mutations for patients with advanced pancreatic cancer. ABSTRACTIntroduction: Exceptional response to therapy is rare in patients with advanced pancreatic cancer. This study explored potential genomic differences between typical and exceptional responses that could confer more favorable biology.
-
Dec 15, 2023 |
December 15, 2023OncologyONCOLOGY Vol 37, Issue 12Pages: 488-495Suneel K. Kamath, MD, et al investigated exceptional responders and the correlation of nonsynonymous mutations for patients with advanced pancreatic cancer. ABSTRACTIntroduction: Exceptional response to therapy is rare in patients with advanced pancreatic cancer. This study explored potential genomic differences between typical and exceptional responses that could confer more favorable biology.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →